188 related articles for article (PubMed ID: 38329740)
41. Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A.
Chhablani J; Rao HB; Begum VU; Jonnadulla GB; Goud A; Barteselli G
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1416-22. PubMed ID: 25655800
[TBL] [Abstract][Full Text] [Related]
42. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography.
Spaide RF; Klancnik JM; Cooney MJ
JAMA Ophthalmol; 2015 Jan; 133(1):66-73. PubMed ID: 25317692
[TBL] [Abstract][Full Text] [Related]
43. Optical coherence tomographic features of macular telangiectasia type 2: Korean Macular Telangiectasia Type 2 Study-Report No. 1.
Kim YH; Chung YR; Oh J; Kim SW; Lee CS; Yun C; Lee B; Ahn SM; Choi EY; Jang S; Lee K
Sci Rep; 2020 Oct; 10(1):16594. PubMed ID: 33024250
[TBL] [Abstract][Full Text] [Related]
44. OCT of Outer Retinal Hyperreflectivity, Neovascularization, and Pigment in Macular Telangiectasia Type 2.
Krivosic V; Lavia C; Aubineau A; Tadayoni R; Gaudric A
Ophthalmol Retina; 2021 Jun; 5(6):562-570. PubMed ID: 32956858
[TBL] [Abstract][Full Text] [Related]
45. Retinal crystals in type 2 idiopathic macular telangiectasia.
Sallo FB; Leung I; Chung M; Wolf-Schnurrbusch UE; Dubra A; Williams DR; Clemons T; Pauleikhoff D; Bird AC; Peto T;
Ophthalmology; 2011 Dec; 118(12):2461-7. PubMed ID: 21839520
[TBL] [Abstract][Full Text] [Related]
46. Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2.
Moir J; Amin SV; Khanna S; Komati R; Shaw LT; Dao D; Hariprasad SM; Skondra D
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887197
[TBL] [Abstract][Full Text] [Related]
47. Validation and Clinical Applicability of Whole-Volume Automated Segmentation of Optical Coherence Tomography in Retinal Disease Using Deep Learning.
Wilson M; Chopra R; Wilson MZ; Cooper C; MacWilliams P; Liu Y; Wulczyn E; Florea D; Hughes CO; Karthikesalingam A; Khalid H; Vermeirsch S; Nicholson L; Keane PA; Balaskas K; Kelly CJ
JAMA Ophthalmol; 2021 Sep; 139(9):964-973. PubMed ID: 34236406
[TBL] [Abstract][Full Text] [Related]
48. Functional Relevance of Hyper-Reflectivity in Macular Telangiectasia Type 2.
Tzaridis S; Friedlander M;
Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):6. PubMed ID: 33661283
[TBL] [Abstract][Full Text] [Related]
49. Automated classification of normal and Stargardt disease optical coherence tomography images using deep learning.
Shah M; Roomans Ledo A; Rittscher J
Acta Ophthalmol; 2020 Sep; 98(6):e715-e721. PubMed ID: 31981283
[TBL] [Abstract][Full Text] [Related]
50. Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia.
McLenachan S; Balaratnasingam C; Heath Jeffery RC; Chen SC; Zhang D; Chan G; Dolz-Marco R; Bacci T; Lo J; Wiffen S; Yannuzzi LA; Chen FK
Exp Eye Res; 2022 May; 218():109024. PubMed ID: 35271830
[TBL] [Abstract][Full Text] [Related]
51. Agreement between time-domain and spectral-domain optical coherence tomography in the assessment of macular thickness in patients with idiopathic macular telangiectasia type 2.
Mathew R; Sivaprasad S; Florea D; Leung I; Sallo F; Clemons T; Bird AC; Peto T
Ophthalmologica; 2013; 230(3):144-50. PubMed ID: 23989133
[TBL] [Abstract][Full Text] [Related]
52. Clinically relevant deep learning for detection and quantification of geographic atrophy from optical coherence tomography: a model development and external validation study.
Zhang G; Fu DJ; Liefers B; Faes L; Glinton S; Wagner S; Struyven R; Pontikos N; Keane PA; Balaskas K
Lancet Digit Health; 2021 Oct; 3(10):e665-e675. PubMed ID: 34509423
[TBL] [Abstract][Full Text] [Related]
53. Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2.
Baumüller S; Charbel Issa P; Scholl HP; Schmitz-Valckenberg S; Holz FG
Ophthalmology; 2010 Nov; 117(11):2162-8. PubMed ID: 20557944
[TBL] [Abstract][Full Text] [Related]
54. Microvascular changes precede visible neurodegeneration in fellow eyes of patients with asymmetric type 2 macular telangiectasia.
Chandran K; Giridhar A; Gopalakrishnan M; Sivaprasad S
Eye (Lond); 2022 Aug; 36(8):1623-1630. PubMed ID: 34326496
[TBL] [Abstract][Full Text] [Related]
55. Classification of diabetes-related retinal diseases using a deep learning approach in optical coherence tomography.
Perdomo O; Rios H; Rodríguez FJ; Otálora S; Meriaudeau F; Müller H; González FA
Comput Methods Programs Biomed; 2019 Sep; 178():181-189. PubMed ID: 31416547
[TBL] [Abstract][Full Text] [Related]
56. Retinal cavitations in macular telangiectasia type 2 (MacTel): longitudinal structure-function correlations.
Cai CX; Choong J; Farsiu S; Chiu SJ; Chew EY; Jaffe GJ
Br J Ophthalmol; 2021 Jan; 105(1):109-112. PubMed ID: 32152145
[TBL] [Abstract][Full Text] [Related]
57. Predicting effectiveness of anti-VEGF injection through self-supervised learning in OCT images.
Feng D; Chen X; Wang X; Mou X; Bai L; Zhang S; Zhou Z
Math Biosci Eng; 2023 Jan; 20(2):2439-2458. PubMed ID: 36899541
[TBL] [Abstract][Full Text] [Related]
58. Point based weakly semi-supervised biomarker detection with cross-scale and label assignment in retinal OCT images.
Liu X; Zhu X; Zhang Y; Wang M
Comput Methods Programs Biomed; 2024 Jun; 251():108229. PubMed ID: 38761413
[TBL] [Abstract][Full Text] [Related]
59. Cervical optical coherence tomography image classification based on contrastive self-supervised texture learning.
Chen K; Wang Q; Ma Y
Med Phys; 2022 Jun; 49(6):3638-3653. PubMed ID: 35342956
[TBL] [Abstract][Full Text] [Related]
60. Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2.
Tzaridis S; Hess K; Friedlander M; Holz FG
Br J Ophthalmol; 2021 May; 105(5):735-740. PubMed ID: 32513667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
